Introduction
The tissue response to implanted biomaterials is a complex cascade of biological processes typically defined by inflammatory and wound healing responses to injury and foreign body www.advancedsciencenews.com www.advhealthmat.de responses surrounding the implant. If the implant causes a disturbance in bone remodeling, the continuous activation of macrophages and osteoclast cells can outbalance osteoblastic activity and result in excessive peri-implant bone resorption, ultimately leading to implant failure. [2] To produce optimal material-tissue interactions, modern biomaterial implants have focused on maximizing biocompatibility and bioactivity, with the intent of minimizing the foreign body reaction and fibrous capsule formation. These properties, along with biodegradability, are particularly relevant for the development of novel bone graft substitutes, but few studies in this area have specifically investigated the relevant material-bone interactions that reflect long-term implant performance. The primary aim of this study is to investigate the microscopic material-tissue interactions and degradation behavior of a novel baghdadite scaffold implanted as a bone graft substitute for the repair of a criticalsized segmental defect in sheep tibia. Extensive bone loss from trauma, tumor resection, or infection is associated with impaired healing, the adequate treatment of which has remained a longstanding clinical problem. Bone defects above a certain critical size, typically 3 cm or larger in humans, exceed the natural regenerative capacity of bone and frequently result in nonunion or delayed healing even with surgical intervention. [3] Autologous bone grafts remain the gold standard for treating large bone defects, and produce excellent healing outcomes currently unmatched by other types of grafts such as allografts and synthetic bone substitutes. [4] However, repairing a large bone defect using bone autografts becomes more impractical with increasing defect size, due to the large volume of bone that needs to be harvested from the donor site, which is further complicated by the high resorption rates of autologous bone after implantation. Driven by the limited supply of bone autografts and their increased risk of complications due to second-site surgery, as well as the inability of bone allografts to achieve the same healing outcomes as autografts due to reduced bioactivity, a number of bone graft substitutes have faced the market in the past 30 years with many more still in development.
The current market for bone graft substitutes is dominated by bioactive ceramics composed of calcium phosphates and bioactive glasses. While these materials are often highly bioactive with the ability to actively induce bone formation through mechanisms such as bioactive ion release and surface interactions, their applications have been limited to particulate bone fillers and poorly interconnected macroporous blocks, mainly for treating contained bone defects at nonload bearing sites. [3] These bone graft substitutes are less useful for repairing large bone defects, particularly defects involving segmental bone loss, due to the inability of particulate material to remain in place or macroporous blocks to facilitate sufficient bone penetration and ingrowth. Additional problems are encountered in the treatment of segmental defects in long bones due to the requirement for high mechanical strength to restore load bearing function.
To address the above drawbacks of current bone graft substitutes, one of the major advances in the field of bone tissue engineering is the development of novel implants intended for the repair of large bone defects, including segmental defects and those at load bearing sites. [5] These implants often contain bioactive ceramics as a major constituent, and are equipped with many of the desirable characteristics for inducing functional bone regeneration, such as high porosity and interconnectivity, mechanical competence to allow repeated load bearing, high bioactivity to encourage osteogenic activity of host cells, and ability to be manufactured with custom shapes and dimensions to match the defect. Some of these implants have been tested for translation potential, with reports of preclinical tests being conducted in large animal models. The ovine model is a common large animal model chosen in these studies, with the defect being created in a weight-bearing region of the bone, which provides similarities in bone composition, bone biology, defect sizes, and healing mechanisms compared to humans. [6] For example, an extensive series of evaluations involving tubular scaffolds of medical-grade polycaprolactone (PCL) incorporating 20% β-tricalcium phosphate (β-TCP) microparticles was performed in an ovine model of a critical-sized, 3 cm tibial middiaphyseal segmental bone defect. The scaffold was implanted for 12 months with or without the addition of autologous mesenchymal stem cells or recombinant human bone morphogenetic protein-7 (rhBMP-7), [7] for 12 weeks with the addition of autologous or allogeneic ovine mesenchymal progenitor cells, [8] and for three months with the addition of low and high doses of rhBMP-7. [9] Using similar ovine models of tibial segmental bone defects, other studies tested ceramic scaffolds of proprietary compositions in 4.5 cm defects for 20-24 weeks with or without the addition of bone marrow stromal cells, [10] and in 3 cm defects for nine months with or without the addition of mesenchymal precursor cells. [11] Another set of studies used a critical-sized, wedge-shaped defect (width 14 mm, length 24 mm, height 6 mm) in the trabecular bone 3 mm distal of the medial tibial plateau. This weight-bearing defect was used to evaluate scaffolds composed of nanocrystalline hydroxyapatite embedded in a porous silica gel matrix over 26 weeks, [12] or strontium-doped calcium phosphate cement scaffolds over six months. [13] These studies collectively indicated low or minimal bone formation for scaffold-only implantations in the ovine critical-sized defects, which was generally enhanced by the addition of cells or growth factors. Most studies evaluated the morphology and distribution (by histology), amount [by microcomputed tomography (µ-CT)], and functional properties (by biomechanical testing) of the newly formed bone within the implants, but only a few studies performed additional histological analyses to specifically investigate the cell and tissue interactions at the material-bone interface. [7, 12, 13] Such analyses are important for understanding the potential mechanisms leading to bone formation following scaffold implantation, as well as remodeling activities that can enable predictions of long-term healing outcomes.
Recently, we evaluated the performance of baghdadite scaffolds implanted as tubular grafts in 3 cm critical-sized middiaphyseal segmental defects in sheep tibia over 26 weeks. [14] We previously developed the bioactive ceramic baghdadite (Ca 3 ZrSi 2 O 9 ) by doping zirconium into the crystal structure of calcium silicate. Through in vitro evaluations, we confirmed the promising mechanical properties of baghdadite, determined the material-cell interactions that resulted in its ability to upregulate the osteogenic activity of human primary bone-derived cells and stem cells, [15, 16] and demonstrated its in vivo capacity www.advancedsciencenews.com www.advhealthmat.de to induce bone formation as a scaffold-only implant in a rabbit segmental defect model over 12 weeks. [17] In the ovine model, the extent of repair achieved by baghdadite scaffolds was analyzed at 26 weeks postimplantation by radiography, biomechanical testing, µ-CT, and histology. [14] Baghdadite scaffolds achieved significant bridging (average 80%) of the critical-sized segmental defect in all samples, with substantial volume of bone infiltration and evidence of bone remodeling within the implant, in the absence of supplementation with cells or growth factors. [14] In the present study, we proceeded to evaluate specifically the in vivo material-tissue interactions and scaffold degradation at the bone-implant interface, to understand the mechanisms by which baghdadite scaffolds can induce bone formation in a large animal model in the absence of added cells or growth factors. Results obtained using focused ion beam scanning electron microscopy (FIB-SEM), multiphoton microscopy, and histology indicated that the baghdadite scaffolds were highly bioactive, causing extensive bone formation that directly abutted the implant surfaces with no evidence of a chronic inflammatory response or fibrous capsule formation. The scaffolds underwent slow in vivo degradation, which influenced bone remodeling around and within the implant, and caused gradual maturation of the newly formed bone. These findings have important implications for predicting the long-term effects of baghdadite ceramics in promoting defect healing, and support the translation of baghdadite scaffolds as a new generation of bone graft substitutes with improved properties for the repair of large bone defects. This study also highlights the importance of understanding the implant-specific material-tissue interactions for predicting the long-term outcomes of bone repair using synthetic substitutes.
Results

FIB-SEM Analysis
FIB-SEM analysis was performed on the unstained histological sections of tibial samples obtained at 26 weeks postimplantation. Regions of interest were selected to contain parts of the baghdadite scaffold surrounded by newly formed bone and highly cellular loose connective tissue (Figure 1 ). At lower magnification in backscatter SEM imaging, the baghdadite scaffold is distinguishable as white material containing some black voids, which are likely to be the remnant spaces left by the polymer sponge template fabrication method ( Figure 1A ). The gray material is mineralized lamellar bone containing visible osteons, while the dark gray areas represent carbon-rich loose connective tissue, among which some baghdadite fragments are visible. At higher magnification, extensive new bone formation (gray) is present surrounding the baghdadite ceramic (light gray) and directly abutting its surface ( Figure 1B ). Degrading ceramic fragments can be found in both the loose connective tissue (dark gray) and in the mature bone already formed around the implant. Focusing specifically on a ceramic strut to show the material-bone interface, the close interdigitation of ceramic (white) and bone (gray) is clearly visible with no fibrous tissue formation ( Figure 1C ). The border between the ceramic and bone is almost completely assimilated with no observable gap, and small particles of the ceramic can be seen incorporated into the bone immediately adjacent to the ceramic-bone interface. Mineralized bone surrounding the ceramic exhibits normal osseous structure, with an abundance of visible osteocytes and canaliculi. Another high-magnification image confirms the tight abutment of bone at the edge of the implant, completely sealing off the ceramic border with no gap at the interface ( Figure 1D ). Degraded ceramic particles are clearly seen to be embedded within the newly formed bone. X-ray elemental mapping of the same image shows the distribution of Ca, Si, Zr, C, O, and P ( Figure 1E ). Ca, O, and Zr are present in both ceramic and bone, while Si is present only in the ceramic, P is present mainly within the bone, and C is present only within the loose connective tissue surrounding the implant. The Ca and C elemental maps collectively show lacunae in the mineralized bone, which are filled with carbon-rich material that likely represent nesting osteocytes. FIB cross-sectioning reveals the bone-scaffold interface in nanoscale detail ( Figure 1F ). Bone infiltration into the scaffold is clearly visible within a 20 µm layer at the interface, which shows intimate nanoscale contact between the mineralized bone and the ceramic even in submicrometer spaces. Small cracks are present in some places within the interface region, where particles of the ceramic have been pulled away from the scaffold and incorporated into the adjacent bone. Vertical grooves seen throughout the image are the result of curtaining effects during ion-beam polishing, and are not intrinsic to the specimen. The white material at the top of the image is a FIB-deposited Pt protective layer. An image of the original bone is included for comparison, and clearly shows the characteristic appearance of mature lamellar bone ( Figure 1G ).
Multiphoton Microscopy Analysis
Multiphoton microscopy analysis was performed on the unstained histological sections of tibial samples obtained at 26 weeks postimplantation. Regions of interest were selected at different points along the section to include (1) the original bone, (2) new bone within the baghdadite scaffold near the edge of the defect, and (3) new bone within the baghdadite scaffold toward the middle of the defect (Figure 2A) . The sections were imaged to visualize the morphology and distribution of collagen type I fibers and autofluorescent bone tissue situated around and within the baghdadite implant ( Figure 2B ). The autofluorescence mainly derives from active and proliferating cells in zones of new bone formation, and also potentially from extracellular matrix structures but to a lesser degree. In the original bone outside the defect (region 1), the collagen fiber network and autofluorescent tissue clearly follow the structure of lamellar bone, which has a highly organized appearance and shows the characteristic features of mature bone, including osteons and channel-like structures resembling Haversian canals ( Figure 2B1 ,2). For the new bone within the baghdadite scaffold near the edge of the defect (region 2), the alignment of collagen fibers indicates the presence of lamellar bone that is less organized compared to the original bone outside the defect ( Figure 2B3 ). The vertically aligned collagen fibers and fiber bundles in the left of the image are characteristic of Figure 2B5,6 ). There is little alignment in the newly formed collagen matrix and no presence of clearly identifiable cell types.
Histological Analysis
Sections of the tibial samples containing the baghdadite scaffolds at 26 weeks postimplantation were stained with toluidine blue and used to perform histological analysis. All images showed bone formation in close apposition to the implant with no presence of chronic inflammation or fibrous capsule formation. Images obtained within the baghdadite implant toward the middle of the defect showed evidence of bone formation through endochondral ossification ( Figure 3A) . Fibrocartilaginous tissue is seen in the center of the image (pink), with a predominantly fibrous appearance and some embedded round chondrocyte-like cells. This extends into cartilaginous tissue rich in chondrocyte-like cells (dark pink), which serves as a template that is progressively converted into mineralized bone (purple and black). These fibrocartilaginous and cartilaginous tissues exhibit the characteristic metachromasia (color change) observed when cartilage is stained using toluidine blue, due to their high proteoglycan content. Some remnants of the cartilaginous template are visible within the bone where remodeling into mineralized bone is not yet complete. In other areas, bone can be seen forming around partially degraded ceramic fragments ( Figure 3B ). The ceramic fragments (black) are surrounded by immature bone (dark purple) that shows evidence of remodeling, with woven bone present in the top left of the image transitioning into lamellar bone toward the bottom right. There is evidence of vascularization that can be distinguished by the lumen of the newly formed blood vessels. Tartrate-resistant acid phosphatase (TRAP) staining (red) shows osteoclast-specific activity localized along the borders of the ceramic, suggesting possible material-cell interactions on the ceramic surface that may contribute to enzymatic degradation of the material or bone remodeling ( Figure 3C ). An image taken at higher magnification in an area within the baghdadite implant toward the edge of the defect shows the presence of more mature bone compared to the middle ( Figure 3D ). The new bone (purple) can be seen directly abutting the ceramic (gray), forming a tight interface with minimal gaps and no fibrous tissue. Woven bone is present immediately adjacent to the ceramic within a ≈2 µm thick layer, which transitions into lamellar bone further away from the ceramic.
Discussion
A primary focus of bone tissue engineering is to achieve longterm healing of large bone defects with outcomes comparable www.advancedsciencenews.com www.advhealthmat.de to those obtained using bone autografts. Recent research has led to the development of new bone graft substitutes with improved properties compared to clinically available products, and a number of these have been tested for their efficacy in repairing bone defects in large animal models. The outcome of bone repair using synthetic materials is primarily controlled by the biocompatibility, bioactivity, and biodegradability of the implant, properties which are intimately linked with the material-tissue interactions triggered by the implant following its placement in the body. However, driven by the urgent need to translate new products to clinical use, many preclinical studies performed in animal models tend to focus on measuring the tangible outcomes of defect healing, such as the volume, morphology, and biomechanical properties of the newly formed bone, and methods to improve these outcomes through the addition of different cell types or growth factors. In this evaluation process, the importance of analyzing the material-tissue interactions that dictate the long-term performance of the synthetic graft is largely overlooked, and ongoing activities such as implant degradation and remodeling of the newly formed bone remain poorly understood. Gaining specific insight into the material-tissue interactions may help explain the sometimes large variations in healing outcomes achieved by synthetic bone substitutes in large defects, even when the same treatment (such as the same type and dose of growth factor) has been applied to all implants. [9] In this study, a series of microscopic analyses were performed to specifically investigate the material-tissue interactions induced by highly porous and bioactive baghdadite scaffolds, following a 26-week implantation period in critical-sized segmental bone defects in sheep tibia. Our previous findings indicated that the baghdadite scaffolds were able to induce almost complete bridging of the critical-sized defect in all experimental animals, as well as extensive bone infiltration into the scaffold pores. [14] New bone formation was found to proceed both along the implant periphery to bridge the defect, and through the structure of the scaffold at a slower rate to occupy the empty pores. Interestingly, these activities occurred in the complete absence of any added cells or growth factors within the implanted scaffolds. In addition, the implanted baghdadite scaffolds did not appear to cause any chronic inflammatory responses in any of the animals, as observed through gross clinical assessment at 3, 12, and 26 weeks postimplantation and histological analysis after sacrifice at 26 weeks. To better understand the in vivo behavior of the baghdadite scaffolds and the manner in which they control the mode of bone formation and remodeling around and within the implant site, we conducted additional analyses on unstained plastic-embedded sections using FIB-SEM, multiphoton microscopy, and histological methods.
To the best of our knowledge, this study is the first to specifically image the implant-bone interface using methods such as FIB-SEM and multiphoton microscopy, for analyzing bone repair using a synthetic implant in a clinically relevant bone defect model. These analytical methods produce highly valuable data on material-tissue interactions that well complement the standard outcome measures relating to the morphology, amount, and functional properties of the newly formed bone. Because they can be applied on unstained sections obtained from hard tissue histology, similar to the procedures undertaken in this study, analysis-specific sample processing is not required and constitutes a major advantage of using these techniques. FIB-SEM is a highly sensitive method for detecting changes in the composition or microstructure of biological or synthetic materials. [18] When applied in this study, it showed clear distinction between the ceramic implant, mineralized bone, and loose connective tissue at high resolution, which cannot be easily achieved with traditional electron microscopy techniques. The use of FIB cross-sectioning ( Figure 1F ), which applies no mechanical force to the material, demonstrated that mechanical sectioning of the specimen has not caused the dislodgement of ceramic particles or their relocation away from the scaffold. This confirmed that the surface observations obtained (Figure 1 ) represent the true 3D nature of the sample. Multiphoton microscopy is a powerful tool for following extracellular matrix production during in vitro or in vivo tissue regeneration. [19] In this study, it was used to specifically image collagen type I fibers in the newly formed bone, allowing detailed observations of bone collagen maturation within the implant along the entire length of the defect. The successful application of FIB-SEM and multiphoton microscopy in this study supports their future use as routine methods for the analysis of in vivo bone repair outcomes in the preclinical evaluation of bone graft substitutes. FIB-SEM and histological analyses confirmed that baghdadite scaffolds induced bone formation that directly abutted the ceramic, with no gaps or fibrous capsule formation at the bone-scaffold interface. These observations reflect the highly bioactive nature of the baghdadite scaffolds, suggesting that they do not cause any ongoing chronic inflammation or foreign body responses that may jeopardize long-term healing of the defect. In most areas where newly formed bone is found surrounding the scaffold struts, there is seamless integration at the bone-scaffold interface, a characteristic which is not frequently observed in comparable studies. In the few studies which showed histological images of the bone-scaffold interface for synthetic scaffold implants in ovine models of criticalsized bone defects, there is often a small gap between the scaffold and the surrounding newly formed bone. [7, 12] Tight bone apposition to the baghdadite scaffold may be induced by slow scaffold degradation, resulting in the shedding of small ceramic fragments or particles that become embedded in both the loose connective tissue and in the newly formed mineralized bone. As shown by FIB-SEM at nanoscale resolution, ceramic particles have migrated away from the scaffold and become fully enveloped in new bone tens of micrometers away from the bone-scaffold interface, suggesting an outward diffusion of the degrading scaffold material during bone growth. These bioactive ceramic fragments appear to be inducing cells in the loose connective tissue to undergo differentiation along the osteoblast lineage. Due to the relatively large surface area to volume ratio of the ceramic fragments compared to the bulk implant, they may actively raise the concentration of bioactive ions (including Ca and Si) [17] in the peri-implant region and create a microenvironment that is conducive to bone formation. Cells responding to this microenvironment are induced to deposit new bone, immobilizing the ceramic fragments in the process. Complete degradation of the baghdadite scaffold is therefore unlikely, since parts of the scaffold are incorporated into the newly formed bone. This is confirmed by the histological findings, where the scaffold struts are often directly abutted by woven bone that transitions into lamellar bone further away from the ceramic. In regions where there is tight abutment of bone around an entire scaffold strut, which indicates complete incorporation of the ceramic into new bone, bone cells such as osteoclasts and osteoblasts are not visible around the boneceramic interface. In these regions, the ceramic has been sealed off by the new bone and is unlikely to undergo further degradation since cells can no longer access the ceramic.
Multiphoton microscopy and histological analyses confirmed continuous bone ingrowth into the baghdadite scaffolds from the proximal and distal defect borders toward the center, accompanied by gradual transition from lamellar to woven bone. The presence of newly formed bone was found throughout the scaffold, even in the center region corresponding to the middle of the defect, suggesting that baghdadite scaffolds can induce ongoing bone formation and remodeling within the implant and eventual replacement of the entire defect with bone. Collagen deposition in the newly formed bone, as visualized through multiphoton second harmonic generation (SHG) microscopy, shows obvious transition from an organized to a disorganized appearance progressing from the edges toward the middle of the defect, indicating the continuous ingrowth of new bone and the presence of most recently formed bone in the center of the implant. This is confirmed by the histological findings that show ongoing remodeling of woven into lamellar bone in the vicinity of degraded baghdadite ceramic fragments. It is likely that baghdadite scaffolds cause bone formation to occur through a biomimetic pathway analogous to endochondral ossification, whereby a cartilaginous template is first formed among the provisional fibrous tissue deposited as part of the natural healing response to injury. This cartilaginous template is progressively remodeled into woven and then lamellar bone, supported by the development of new blood vessels, resulting in the formation of anatomically similar vascularized bone. Bone formed through endochondral ossification imitates the characteristics of naturally occurring long bones, which have distinctly different characteristics compared to bone formed through many cell-based bone tissue engineering strategies that replicate intramembranous ossification. [5] Detailed histological analysis suggests the involvement of cell-mediated processes in the in vivo degradation of baghdadite scaffolds. Osteoclast-specific activity can be distinguished on the surface of the ceramic in some areas of the scaffold through TRAP staining (red), and cell infiltration into the scaffold struts is frequently evident through toluidine blue staining (purple) that is present inside the ceramic. These observations possibly reflect the processes of cell-mediated degradation and bone remodeling on the surface of the ceramic. Similar processes of osteoclast-mediated degradation and remodeling at the scaffold-bone interface have been reported in other studies testing synthetic scaffolds in ovine models of critical-sized bone defects. [12, 13] For bioactive scaffolds such as baghdadite, these processes may be essential for releasing bioactive ions from the ceramic to trigger bone formation, and eventual incorporation of the ceramic into the structure of the newly formed bone.
Based on the results of FIB-SEM and histology, relatively mature lamellar bone is present within the scaffold toward the edge of the defect and also within the proximal and distal one-third of the defect area. Beyond this toward the middle of the defect, there is an advancing edge of bone-containing immature woven bone, cartilage templates, and small amounts of fibrous tissue. This indicates a gradual replacement of immature tissue by more mature bone tissue that progresses from the defect edges toward the middle, which is verified by the multiphoton microscopy images taken at different locations along the defect. Taken together, it is likely that the transition from immature to mature bone occurs somewhere within the middle one-third of the defect. It is possible that some local in vivo degradation of the baghdadite scaffold is necessary to induce bone formation at different locations within the implant, due to the creation of a richly mineralized environment. Osteoclast activity may be equally responsible for remodeling the newly formed bone and further degradation of the baghdadite scaffold beyond the advancing front of new bone, thereby modulating continuous bone formation within the scaffold.
The results of this study reveal important material-tissue interactions that enable predictions of the long-term in vivo behavior of baghdadite scaffolds in the repair of large bone defects. It is expected that the scaffold will be incorporated and remodeled together with the new bone during the healing process rather than to undergo complete degradation. This may be advantageous because the scaffold will be present for sufficiently long periods of time to provide adequate mechanical support during healing, rather than be rapidly degraded and leave behind a defect filled with immature tissue that cannot fulfill physiological functions. [7] Incorporation of the baghdadite scaffold into the newly formed bone will not jeopardize long-term remodeling into the original osseous structure (with cortical shell and marrow space), due to its ability to be degraded by cell-mediated processes such as osteoclastic resorption. Additional insights may be gained in future studies by comparing the tissue responses and bone repair processes induced by baghdadite scaffolds to other bone graft substitute materials, as well as over longer implantation times.
Conclusion
By providing clarification on the in vivo material-tissue interactions induced by baghdadite scaffolds, this study complements our previous findings on bone repair outcomes in a clinically relevant defect models, which included morphological, quantitative, and functional assessment of the newly formed bone. Analyses performed using FIB-SEM, multiphoton microscopy, and histological methods in this study confirmed the high bioactivity of baghdadite scaffolds and their ability to induce favorable interactions with host bone tissue. The combined characteristics of baghdadite scaffolds give confidence to their ability to promote long-term defect healing, which includes restoration of the original anatomical and functional properties of the injured bone. This supports future steps to advance the translation of baghdadite scaffolds as improved bone graft substitutes for the clinical treatment of large bone defects. Furthermore, this study highlights the importance of understanding the implant-specific material-tissue interactions for predicting long-term bone repair outcomes using synthetic implants.
www.advancedsciencenews.com www.advhealthmat.de stacks were recorded through the whole volume of detectable collagen-I network (80-200 µm) using 4× averaging. Images were optimized for brightness and contrast using Fiji software (NIH, USA). Histological Analysis: Unstained sections of samples were etched with 2% acid ethanol for 10 min to allow aqueous staining. The sections were stained on one surface only using 0.1% toluidine blue, rinsed in distilled water, air dried, and mounted on slides using Ultramount. To visualize TRAP enzyme activity, the sections were stained on one surface only using a TRAP Staining Kit (Cosmo Bio, Japan), prior to counterstaining using 0.1% toluidine blue. An optical microscope (Olympus BX51 equipped with an Olympus DP71 camera, Japan) was used to image cell and tissue interactions around and within the implant at high magnifications.
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